Hemorrhagic Coagulation Disorders and Ischemic Stroke: How to Reconcile Both?

Area of Science:

• Hematology
• Neurology
• Pathophysiology

Background:

• Coagulation and fibrinolytic system disorders impair blood clotting, increasing risks of thrombosis or bleeding.
• These opposing tendencies can coexist or result from each other, complicating prognoses for acute cerebrovascular events.
• Identifying dual alterations in these systems is crucial for mitigating negative impacts in challenging clinical scenarios.

Purpose of the Study:

• To review conditions with dual alterations in coagulation and fibrinolysis.
• To guide the management of patients with acute neurological syndrome experiencing these complex hemostatic challenges.
• To highlight future directions in managing these pathologies.

Main Methods:

• Literature review focusing on the interplay between coagulation and fibrinolysis in neurological syndromes.
• Analysis of clinical management strategies for patients with combined hemostatic defects.
• Exploration of emerging treatments and diagnostic approaches.

Main Results:

• Dual alterations in coagulation and fibrinolysis present significant management challenges, requiring a balance between preventing bleeding and thrombosis.
• Individualized treatment is essential, considering the specific disorder, severity, and patient's overall condition.
• Stroke can be a consequence of these hemostatic imbalances or the first sign of underlying pathology.

Conclusions:

• Effective management of acute neurological syndromes necessitates understanding the dual role of coagulation and fibrinolysis.
• Precision medicine, personalized treatments, advanced anticoagulation, and bleeding control innovations are vital for future therapeutic strategies.
• Recognizing and addressing these complex hemostatic disorders can improve patient outcomes.